Lantern Pharma Inc

Research Lantern Pharma Inc (LTRN) on Bullrun: market cap USD 51.93M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLTRN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 51.93M
• Financial periodFY2025
• Net income-USD 17.12M
• Free cash flow-USD 15.68M

Valuation Snapshot

latest market cap is USD 51.93M.

About Lantern Pharma Inc

Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma;

Frequently asked questions

What is Lantern Pharma Inc's market cap?

Lantern Pharma Inc's market capitalization is USD 51.93M.

What does Lantern Pharma Inc do?

Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma;